Suggestions
Dr Marek Tyl
Corporate Venture Capital | Business Development | Cell and Gene
Dr. Marek Tyl is the New Business Development Manager for Cell Biology within Corporate Venture Capital at Eppendorf Group. He is based in the London Area, United Kingdom, and has a strong academic background, holding a Ph.D. in Biochemistry from the University of Cambridge, which he completed between 2009 and 2012.12
In addition to his role at Eppendorf, Dr. Tyl is a co-founder and the Chief Executive of the Innovation Forum, a global network aimed at connecting young researchers and industry professionals.3 His professional network on LinkedIn includes over 500 connections, indicating a robust engagement within his field.1